Skip to main content
. 2016 Aug 12;12(3):224–247. doi: 10.1007/s13181-016-0580-6

Table 31.

Clinical signs—other organ systems

N (%)a
Metabolic
 Hypoglycemia (glucose < 50 mg/dL) 382 (4.7)
 Elevated anion gap (>20) 321 (4.0)
 Metabolic acidosis (pH < 7.2) 140 (1.7)
 Elevated osmole gap (>20) 78 (1.0)
 Total 921 (11.3)b
Gastrointestinal/hepatic
 Hepatotoxicity (AST ≥ 1000 IU/L) 261 (3.2)
 Pancreatitis 55 (0.7)
 Gastrointestinal bleeding 45 (0.6)
 Corrosive injury 28 (0.3)
Intestinal ischemia 3 (0.0)
 Total 392 (4.8)b
Hematological
 Coagulopathy (PT > 15 s) 187 (2.3)
 Thrombocytopenia (platelets < 100 K/μL) 96 (1.2)
 Leukocytosis (WBC > 20 K/μL) 88 (1.1)
 Hemolysis (Hgb < 10 g/dL) 40 (0.5)
 Methemoglobinemia (MetHgb ≥ 2 %) 23 (0.3)
 Pancytopenia 12 (0.1)
 Total 446 (5.5)b
Renal/musculoskeletal
 Rhabdomyolysis (CPK > 1000 IU/L) 398 (4.9)
 Acute kidney injury (creatinine > 2.0 mg/dL) 283 (3.5)
 Total 681 (8.4)b
Dermatological
 Rash 122 (1.5)
 Blister/bullae 68 (0.8)
 Necrosis 25 (0.3)
 Angioedema 18 (0.2)
 Total 233 (2.9)b

AST aspartate aminotransferase, PT prothrombin time, WBC white blood cells, Hgb hemoglobin, CPK creatine phosphokinase

aPercentage equals the number of cases reporting specific clinical signs compared to the total number of Registry cases in 2015 (N = 8115)

bTotal reflects cases reporting at least one sign in the category. Cases may be associated with more than one symptom